

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 5.03073800 |
| 2 | carnitine shuttle (GO:0006853) | 4.91268524 |
| 3 | fatty acid transmembrane transport (GO:1902001) | 4.49083597 |
| 4 | carnitine transmembrane transport (GO:1902603) | 4.28742239 |
| 5 | sarcomere organization (GO:0045214) | 4.22115473 |
| 6 | amino-acid betaine transport (GO:0015838) | 4.14505426 |
| 7 | carnitine transport (GO:0015879) | 4.14505426 |
| 8 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.05429598 |
| 9 | cardiac myofibril assembly (GO:0055003) | 4.02724244 |
| 10 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.98849972 |
| 11 | negative regulation of cell size (GO:0045792) | 3.97404290 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 3.93671407 |
| 13 | lysine metabolic process (GO:0006553) | 3.93157924 |
| 14 | lysine catabolic process (GO:0006554) | 3.93157924 |
| 15 | 2-oxoglutarate metabolic process (GO:0006103) | 3.88693952 |
| 16 | regulation of fatty acid oxidation (GO:0046320) | 3.77931119 |
| 17 | muscle filament sliding (GO:0030049) | 3.73366613 |
| 18 | actin-myosin filament sliding (GO:0033275) | 3.73366613 |
| 19 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.72632715 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 3.67695403 |
| 21 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.66261230 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.60954590 |
| 23 | myofibril assembly (GO:0030239) | 3.51251174 |
| 24 | macroautophagy (GO:0016236) | 3.37696524 |
| 25 | tricarboxylic acid metabolic process (GO:0072350) | 3.36305600 |
| 26 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.33628317 |
| 27 | cardiac muscle contraction (GO:0060048) | 3.30463969 |
| 28 | positive regulation of receptor recycling (GO:0001921) | 3.26850848 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 3.22090034 |
| 30 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.20530813 |
| 31 | barbed-end actin filament capping (GO:0051016) | 3.19165005 |
| 32 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.17351449 |
| 33 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.15942935 |
| 34 | positive regulation of fatty acid oxidation (GO:0046321) | 3.13339210 |
| 35 | fibroblast migration (GO:0010761) | 3.12644386 |
| 36 | positive regulation of histone deacetylation (GO:0031065) | 3.12018926 |
| 37 | valine metabolic process (GO:0006573) | 3.12014872 |
| 38 | regulation of skeletal muscle contraction (GO:0014819) | 3.10225767 |
| 39 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.10002811 |
| 40 | quaternary ammonium group transport (GO:0015697) | 3.07793011 |
| 41 | fatty acid beta-oxidation (GO:0006635) | 3.04357122 |
| 42 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.04159723 |
| 43 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.01160617 |
| 44 | oxaloacetate metabolic process (GO:0006107) | 3.00848402 |
| 45 | regulation of cholesterol homeostasis (GO:2000188) | 3.00408690 |
| 46 | regulation of sequestering of triglyceride (GO:0010889) | 2.96847340 |
| 47 | actomyosin structure organization (GO:0031032) | 2.96581754 |
| 48 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.96077618 |
| 49 | low-density lipoprotein particle clearance (GO:0034383) | 2.92510589 |
| 50 | protein targeting to plasma membrane (GO:0072661) | 2.90944861 |
| 51 | actin-mediated cell contraction (GO:0070252) | 2.87700054 |
| 52 | desmosome organization (GO:0002934) | 2.85946909 |
| 53 | 4-hydroxyproline metabolic process (GO:0019471) | 2.85398863 |
| 54 | cell communication involved in cardiac conduction (GO:0086065) | 2.84987740 |
| 55 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.84295328 |
| 56 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.82878693 |
| 57 | sodium ion export (GO:0071436) | 2.82761494 |
| 58 | carnitine metabolic process (GO:0009437) | 2.81926790 |
| 59 | regulation of platelet aggregation (GO:0090330) | 2.81388056 |
| 60 | adherens junction assembly (GO:0034333) | 2.77407131 |
| 61 | striated muscle contraction (GO:0006941) | 2.76301689 |
| 62 | NADH metabolic process (GO:0006734) | 2.75180759 |
| 63 | positive regulation of lipid catabolic process (GO:0050996) | 2.73533124 |
| 64 | focal adhesion assembly (GO:0048041) | 2.72601795 |
| 65 | cell-substrate adherens junction assembly (GO:0007045) | 2.72601795 |
| 66 | cell communication by electrical coupling (GO:0010644) | 2.72395179 |
| 67 | peptidyl-lysine dimethylation (GO:0018027) | 2.71913991 |
| 68 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.70816291 |
| 69 | negative regulation of heart growth (GO:0061117) | 2.69818462 |
| 70 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.69818462 |
| 71 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.67382839 |
| 72 | negative regulation of fatty acid transport (GO:2000192) | 2.66492278 |
| 73 | skeletal muscle adaptation (GO:0043501) | 2.66335895 |
| 74 | glycolytic process (GO:0006096) | 2.65267544 |
| 75 | cell-substrate junction assembly (GO:0007044) | 2.64750066 |
| 76 | regulation of p38MAPK cascade (GO:1900744) | 2.63532295 |
| 77 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.62341467 |
| 78 | negative regulation of protein localization to cell surface (GO:2000009) | 2.62100845 |
| 79 | amino-acid betaine metabolic process (GO:0006577) | 2.61387292 |
| 80 | cardiac muscle cell development (GO:0055013) | 2.61262653 |
| 81 | regulation of cholesterol storage (GO:0010885) | 2.61184751 |
| 82 | actin filament-based movement (GO:0030048) | 2.59748186 |
| 83 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.59732455 |
| 84 | positive regulation of glycogen metabolic process (GO:0070875) | 2.57200579 |
| 85 | fatty acid oxidation (GO:0019395) | 2.54901344 |
| 86 | intracellular lipid transport (GO:0032365) | 2.54879752 |
| 87 | fatty acid homeostasis (GO:0055089) | 2.54595877 |
| 88 | heart trabecula formation (GO:0060347) | 2.54446336 |
| 89 | acetyl-CoA metabolic process (GO:0006084) | 2.54006625 |
| 90 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.53951253 |
| 91 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.52858614 |
| 92 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.51351366 |
| 93 | protein localization to endosome (GO:0036010) | 2.50459912 |
| 94 | cardiac muscle hypertrophy (GO:0003300) | 2.50321535 |
| 95 | fatty acid catabolic process (GO:0009062) | 2.50206915 |
| 96 | cellular response to epinephrine stimulus (GO:0071872) | 2.50084702 |
| 97 | glycogen catabolic process (GO:0005980) | 2.49704401 |
| 98 | stress fiber assembly (GO:0043149) | 2.49642065 |
| 99 | regulation of the force of heart contraction (GO:0002026) | 2.49249421 |
| 100 | positive regulation of myotube differentiation (GO:0010831) | 2.48751008 |
| 101 | cardiac cell development (GO:0055006) | 2.48674354 |
| 102 | lipid oxidation (GO:0034440) | 2.48319443 |
| 103 | NLS-bearing protein import into nucleus (GO:0006607) | 2.46523562 |
| 104 | epithelial cell-cell adhesion (GO:0090136) | 2.44206303 |
| 105 | glycogen metabolic process (GO:0005977) | 2.44105425 |
| 106 | hypotonic response (GO:0006971) | 2.43992509 |
| 107 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.43935947 |
| 108 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.43181325 |
| 109 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.41691132 |
| 110 | heparin biosynthetic process (GO:0030210) | 2.41544809 |
| 111 | heparin metabolic process (GO:0030202) | 2.41544809 |
| 112 | endocardial cushion development (GO:0003197) | 2.40979141 |
| 113 | cellular glucan metabolic process (GO:0006073) | 2.40752494 |
| 114 | glucan metabolic process (GO:0044042) | 2.40752494 |
| 115 | positive regulation of lipid storage (GO:0010884) | 2.40645007 |
| 116 | striated muscle hypertrophy (GO:0014897) | 2.40104947 |
| 117 | regulation of tight junction assembly (GO:2000810) | 2.39580799 |
| 118 | phospholipid dephosphorylation (GO:0046839) | 2.39250739 |
| 119 | Golgi transport vesicle coating (GO:0048200) | 2.38829711 |
| 120 | COPI coating of Golgi vesicle (GO:0048205) | 2.38829711 |
| 121 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.38752882 |
| 122 | regulation of receptor recycling (GO:0001919) | 2.38404412 |
| 123 | glucan catabolic process (GO:0009251) | 2.38330102 |
| 124 | mannose metabolic process (GO:0006013) | 2.32408850 |
| 125 | pericardium development (GO:0060039) | 2.32018505 |
| 126 | negative regulation of stress fiber assembly (GO:0051497) | 2.30460223 |
| 127 | phospholipid scrambling (GO:0017121) | 2.29302620 |
| 128 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.28778721 |
| 129 | peptide catabolic process (GO:0043171) | 2.27202900 |
| 130 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.26726507 |
| 131 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.26668395 |
| 132 | response to epinephrine (GO:0071871) | 2.26433530 |
| 133 | striated muscle atrophy (GO:0014891) | 2.24421510 |
| 134 | relaxation of cardiac muscle (GO:0055119) | 2.24006983 |
| 135 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.18536711 |
| 136 | growth hormone receptor signaling pathway (GO:0060396) | 2.18081494 |
| 137 | actin filament capping (GO:0051693) | 2.16934618 |
| 138 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.15899672 |
| 139 | regulation of protein localization to cell surface (GO:2000008) | 2.14460736 |
| 140 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.14384422 |
| 141 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.12620952 |
| 142 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.10245127 |
| 143 | establishment of protein localization to plasma membrane (GO:0090002) | 2.10209217 |
| 144 | Golgi to plasma membrane protein transport (GO:0043001) | 2.09346603 |
| 145 | platelet aggregation (GO:0070527) | 2.09256048 |
| 146 | membrane raft organization (GO:0031579) | 2.05051198 |
| 147 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.04590352 |
| 148 | actin filament depolymerization (GO:0030042) | 2.03677722 |
| 149 | muscle atrophy (GO:0014889) | 2.02887961 |
| 150 | Golgi to endosome transport (GO:0006895) | 2.02363856 |
| 151 | cellular response to vitamin (GO:0071295) | 2.00462162 |
| 152 | negative regulation of actin filament depolymerization (GO:0030835) | 1.99659633 |
| 153 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 1.99469387 |
| 154 | positive regulation of macrophage differentiation (GO:0045651) | 1.99118657 |
| 155 | skin morphogenesis (GO:0043589) | 1.98881344 |
| 156 | beta-amyloid metabolic process (GO:0050435) | 1.98411737 |
| 157 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 1.97724801 |
| 158 | cellular response to growth hormone stimulus (GO:0071378) | 1.96117535 |
| 159 | cellular response to vitamin D (GO:0071305) | 1.95233798 |
| 160 | myoblast fusion (GO:0007520) | 1.92374655 |
| 161 | membrane protein ectodomain proteolysis (GO:0006509) | 1.91713212 |
| 162 | extracellular fibril organization (GO:0043206) | 1.91364298 |
| 163 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 1.90500147 |
| 164 | negative regulation of cell killing (GO:0031342) | 1.90500147 |
| 165 | regulation of ARF protein signal transduction (GO:0032012) | 1.90436064 |
| 166 | negative regulation of anoikis (GO:2000811) | 1.89886887 |
| 167 | platelet degranulation (GO:0002576) | 1.89574849 |
| 168 | positive regulation of muscle hypertrophy (GO:0014742) | 1.89427737 |
| 169 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 1.89427737 |
| 170 | interleukin-6-mediated signaling pathway (GO:0070102) | 1.89211849 |
| 171 | histone H3-K36 demethylation (GO:0070544) | 1.89109081 |
| 172 | vesicle coating (GO:0006901) | 1.88939722 |
| 173 | syncytium formation by plasma membrane fusion (GO:0000768) | 1.87685006 |
| 174 | negative regulation of actin filament bundle assembly (GO:0032232) | 1.87530427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.20001204 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.74855664 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.94658738 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.84008625 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.75229397 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.73908894 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.63162834 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.52060374 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.48070527 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.44862694 |
| 11 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.42210954 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26569739 |
| 13 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.22163324 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21759531 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.21584732 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.18436435 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.12808918 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.11031196 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08462407 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06704096 |
| 21 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06158421 |
| 22 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.02613256 |
| 23 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.02613256 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99563672 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.98562402 |
| 26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.98359204 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.92318566 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90706478 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84671555 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83110815 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80768317 |
| 32 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.73681412 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73452319 |
| 34 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.73398838 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67685523 |
| 36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67677837 |
| 37 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.64989401 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.64503700 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64118550 |
| 40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.63853246 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61876421 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60236839 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59125675 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.57475561 |
| 45 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.55321110 |
| 46 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.50864858 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49253492 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48360843 |
| 49 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.46307473 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.44675283 |
| 51 | P68_20966046_ChIP-Seq_HELA_Human | 1.44458344 |
| 52 | ATF3_27146783_Chip-Seq_COLON_Human | 1.40533672 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40321374 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37328215 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36756128 |
| 56 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36104481 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35613886 |
| 58 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.35353968 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35313944 |
| 60 | GATA2_19941826_ChIP-Seq_K562_Human | 1.33814532 |
| 61 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33395454 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31960067 |
| 63 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.31823180 |
| 64 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.31455369 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31364764 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.30633711 |
| 67 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.30120726 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29735484 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28144946 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27824654 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27824654 |
| 72 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27693517 |
| 73 | MAF_26560356_Chip-Seq_TH1_Human | 1.24160999 |
| 74 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23945985 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23600357 |
| 76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.23179961 |
| 77 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22158996 |
| 78 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22137455 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22008388 |
| 80 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21805699 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21631594 |
| 82 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.21114846 |
| 83 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20822506 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20757840 |
| 85 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20395619 |
| 86 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.20323268 |
| 87 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.20256068 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19712369 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18612676 |
| 90 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.18556488 |
| 91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18506078 |
| 92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18437594 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15939919 |
| 94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15422903 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15276875 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.14298950 |
| 97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14223886 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13903459 |
| 99 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13223599 |
| 100 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13163216 |
| 101 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13008995 |
| 102 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12974332 |
| 103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.12365591 |
| 104 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.12239210 |
| 105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10668240 |
| 106 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10377809 |
| 107 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09628660 |
| 108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08186175 |
| 109 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.08130431 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07362960 |
| 111 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.06760545 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06646897 |
| 113 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06646897 |
| 114 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.06563761 |
| 115 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06562551 |
| 116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06406348 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05400805 |
| 118 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04738228 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03581084 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03546203 |
| 121 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01971822 |
| 122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01517335 |
| 123 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01254706 |
| 124 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00936884 |
| 125 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00279164 |
| 126 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00151818 |
| 127 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99512077 |
| 128 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.99214193 |
| 129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98794663 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98460112 |
| 131 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98253754 |
| 132 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98045712 |
| 133 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98017559 |
| 134 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97930972 |
| 135 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97578142 |
| 136 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97479362 |
| 137 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97055863 |
| 138 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.95506604 |
| 139 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.95334626 |
| 140 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95283894 |
| 141 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94958097 |
| 142 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93996541 |
| 143 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93876329 |
| 144 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93847693 |
| 145 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93643270 |
| 146 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93377074 |
| 147 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93130428 |
| 148 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92520356 |
| 149 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91962786 |
| 150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91721925 |
| 151 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87897392 |
| 152 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87604125 |
| 153 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86647948 |
| 154 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85544222 |
| 155 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84879961 |
| 156 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84165507 |
| 157 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83816226 |
| 158 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83506440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 3.89017490 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.83517096 |
| 3 | MP0000751_myopathy | 3.77573067 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.51843654 |
| 5 | MP0004130_abnormal_muscle_cell | 3.07757057 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.06212939 |
| 7 | MP0005409_darkened_coat_color | 2.71472486 |
| 8 | MP0000749_muscle_degeneration | 2.70897505 |
| 9 | MP0004087_abnormal_muscle_fiber | 2.61288831 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.59056535 |
| 11 | MP0005670_abnormal_white_adipose | 2.40940518 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.27707431 |
| 13 | MP0004233_abnormal_muscle_weight | 2.20285884 |
| 14 | MP0005330_cardiomyopathy | 2.12461791 |
| 15 | MP0002269_muscular_atrophy | 2.11174738 |
| 16 | MP0005360_urolithiasis | 2.10914735 |
| 17 | MP0005666_abnormal_adipose_tissue | 2.06083458 |
| 18 | MP0010630_abnormal_cardiac_muscle | 1.97365841 |
| 19 | MP0002332_abnormal_exercise_endurance | 1.96368061 |
| 20 | MP0005451_abnormal_body_composition | 1.93440893 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.87106246 |
| 22 | MP0002106_abnormal_muscle_physiology | 1.85673461 |
| 23 | MP0000747_muscle_weakness | 1.84821365 |
| 24 | MP0005410_abnormal_fertilization | 1.81366476 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 1.80190563 |
| 26 | MP0000750_abnormal_muscle_regeneration | 1.80107595 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.78268910 |
| 28 | MP0000759_abnormal_skeletal_muscle | 1.78179896 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.77788066 |
| 30 | MP0006054_spinal_hemorrhage | 1.74015077 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 1.71205046 |
| 32 | MP0005620_abnormal_muscle_contractility | 1.69313520 |
| 33 | MP0008961_abnormal_basal_metabolism | 1.69087288 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.66848135 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.66552056 |
| 36 | MP0009840_abnormal_foam_cell | 1.64470736 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.62905594 |
| 38 | MP0005385_cardiovascular_system_phenoty | 1.62905594 |
| 39 | MP0010329_abnormal_lipoprotein_level | 1.61250147 |
| 40 | MP0005375_adipose_tissue_phenotype | 1.59751426 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.56474007 |
| 42 | MP0002972_abnormal_cardiac_muscle | 1.54927501 |
| 43 | MP0000733_abnormal_muscle_development | 1.52193415 |
| 44 | MP0008775_abnormal_heart_ventricle | 1.51849243 |
| 45 | MP0005365_abnormal_bile_salt | 1.51549053 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.50779304 |
| 47 | MP0008260_abnormal_autophagy | 1.49225735 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.46710932 |
| 49 | MP0005369_muscle_phenotype | 1.45843025 |
| 50 | MP0003252_abnormal_bile_duct | 1.44840825 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.42727623 |
| 52 | MP0006138_congestive_heart_failure | 1.41782776 |
| 53 | MP0008004_abnormal_stomach_pH | 1.41632989 |
| 54 | MP0005275_abnormal_skin_tensile | 1.41518926 |
| 55 | MP0005623_abnormal_meninges_morphology | 1.38507532 |
| 56 | MP0003950_abnormal_plasma_membrane | 1.38301724 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.33944990 |
| 58 | MP0003279_aneurysm | 1.32128504 |
| 59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.32034776 |
| 60 | MP0004510_myositis | 1.32005625 |
| 61 | MP0005083_abnormal_biliary_tract | 1.31112774 |
| 62 | MP0001849_ear_inflammation | 1.23891435 |
| 63 | MP0004858_abnormal_nervous_system | 1.23356809 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 1.22908078 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.19072000 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.19036705 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.16762172 |
| 68 | MP0003329_amyloid_beta_deposits | 1.16427567 |
| 69 | MP0002168_other_aberrant_phenotype | 1.15751134 |
| 70 | MP0003724_increased_susceptibility_to | 1.13495345 |
| 71 | MP0002127_abnormal_cardiovascular_syste | 1.12409880 |
| 72 | MP0000013_abnormal_adipose_tissue | 1.11555638 |
| 73 | MP0001958_emphysema | 1.11531407 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 1.11332120 |
| 75 | MP0002909_abnormal_adrenal_gland | 1.07470892 |
| 76 | MP0003183_abnormal_peptide_metabolism | 1.05854123 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 1.03833339 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.02589435 |
| 79 | MP0002896_abnormal_bone_mineralization | 1.02425118 |
| 80 | MP0002234_abnormal_pharynx_morphology | 1.01468882 |
| 81 | MP0002118_abnormal_lipid_homeostasis | 1.01252401 |
| 82 | MP0000266_abnormal_heart_morphology | 1.01174811 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.00822680 |
| 84 | MP0000609_abnormal_liver_physiology | 0.99342625 |
| 85 | MP0005164_abnormal_response_to | 0.98465565 |
| 86 | MP0004134_abnormal_chest_morphology | 0.96654081 |
| 87 | MP0004484_altered_response_of | 0.96648869 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.96004169 |
| 89 | MP0009278_abnormal_bone_marrow | 0.95155422 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.93763618 |
| 91 | MP0002971_abnormal_brown_adipose | 0.92065608 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.91624257 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.90482707 |
| 94 | MP0005023_abnormal_wound_healing | 0.89999463 |
| 95 | MP0006036_abnormal_mitochondrial_physio | 0.89667222 |
| 96 | MP0002128_abnormal_blood_circulation | 0.89336283 |
| 97 | MP0002060_abnormal_skin_morphology | 0.88846823 |
| 98 | MP0000920_abnormal_myelination | 0.88502206 |
| 99 | MP0001542_abnormal_bone_strength | 0.88413984 |
| 100 | MP0000249_abnormal_blood_vessel | 0.87760319 |
| 101 | MP0003828_pulmonary_edema | 0.86124376 |
| 102 | MP0005165_increased_susceptibility_to | 0.85226186 |
| 103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85184729 |
| 104 | MP0003115_abnormal_respiratory_system | 0.83594465 |
| 105 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82142683 |
| 106 | MP0003045_fibrosis | 0.82004616 |
| 107 | MP0002108_abnormal_muscle_morphology | 0.81374230 |
| 108 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81170411 |
| 109 | MP0003303_peritoneal_inflammation | 0.79795854 |
| 110 | MP0004883_abnormal_blood_vessel | 0.78746312 |
| 111 | MP0005187_abnormal_penis_morphology | 0.78511553 |
| 112 | MP0004272_abnormal_basement_membrane | 0.77949695 |
| 113 | MP0004085_abnormal_heartbeat | 0.76367173 |
| 114 | MP0001661_extended_life_span | 0.76344634 |
| 115 | MP0009115_abnormal_fat_cell | 0.75731141 |
| 116 | MP0004947_skin_inflammation | 0.75620815 |
| 117 | MP0003091_abnormal_cell_migration | 0.74953412 |
| 118 | MP0009780_abnormal_chondrocyte_physiolo | 0.71469937 |
| 119 | MP0005621_abnormal_cell_physiology | 0.70661468 |
| 120 | MP0005503_abnormal_tendon_morphology | 0.70437257 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.68761386 |
| 122 | MP0004197_abnormal_fetal_growth/weight/ | 0.68694277 |
| 123 | MP0000681_abnormal_thyroid_gland | 0.68641218 |
| 124 | MP0005332_abnormal_amino_acid | 0.68566444 |
| 125 | MP0005257_abnormal_intraocular_pressure | 0.67538589 |
| 126 | MP0003656_abnormal_erythrocyte_physiolo | 0.66947946 |
| 127 | MP0009672_abnormal_birth_weight | 0.66734312 |
| 128 | MP0008874_decreased_physiological_sensi | 0.66693639 |
| 129 | MP0005334_abnormal_fat_pad | 0.66567505 |
| 130 | MP0002925_abnormal_cardiovascular_devel | 0.66484880 |
| 131 | MP0001915_intracranial_hemorrhage | 0.66328860 |
| 132 | MP0002877_abnormal_melanocyte_morpholog | 0.66048390 |
| 133 | MP0001666_abnormal_nutrient_absorption | 0.64672373 |
| 134 | MP0005397_hematopoietic_system_phenotyp | 0.64663325 |
| 135 | MP0001545_abnormal_hematopoietic_system | 0.64663325 |
| 136 | MP0000767_abnormal_smooth_muscle | 0.64510421 |
| 137 | MP0000598_abnormal_liver_morphology | 0.64086097 |
| 138 | MP0002998_abnormal_bone_remodeling | 0.63951287 |
| 139 | MP0008770_decreased_survivor_rate | 0.62747530 |
| 140 | MP0002970_abnormal_white_adipose | 0.62397757 |
| 141 | MP0000537_abnormal_urethra_morphology | 0.61874992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.78472569 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 4.59944271 |
| 3 | Myoglobinuria (HP:0002913) | 4.22704022 |
| 4 | Hyporeflexia of lower limbs (HP:0002600) | 4.22087147 |
| 5 | Sudden death (HP:0001699) | 3.97703374 |
| 6 | Increased connective tissue (HP:0009025) | 3.95941069 |
| 7 | Difficulty running (HP:0009046) | 3.86329455 |
| 8 | Muscle fiber splitting (HP:0003555) | 3.45061441 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 3.44694408 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 3.35104126 |
| 11 | Difficulty climbing stairs (HP:0003551) | 3.34785947 |
| 12 | Rhabdomyolysis (HP:0003201) | 3.34753231 |
| 13 | Asymmetric septal hypertrophy (HP:0001670) | 3.30630108 |
| 14 | Ventricular tachycardia (HP:0004756) | 3.29419569 |
| 15 | Bundle branch block (HP:0011710) | 3.26698298 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 3.13953074 |
| 17 | Distal lower limb muscle weakness (HP:0009053) | 3.11042104 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.00514253 |
| 19 | Subaortic stenosis (HP:0001682) | 3.00514253 |
| 20 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.00398361 |
| 21 | Menorrhagia (HP:0000132) | 2.96661935 |
| 22 | Abnormality of the calf musculature (HP:0001430) | 2.92766293 |
| 23 | Increased variability in muscle fiber diameter (HP:0003557) | 2.86852054 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 2.79481193 |
| 25 | Prolonged bleeding time (HP:0003010) | 2.77862953 |
| 26 | Lymphangioma (HP:0100764) | 2.77066756 |
| 27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.73256190 |
| 28 | Distal upper limb amyotrophy (HP:0007149) | 2.70774989 |
| 29 | Upper limb amyotrophy (HP:0009129) | 2.70774989 |
| 30 | Muscle fiber inclusion bodies (HP:0100299) | 2.70019358 |
| 31 | Broad metatarsal (HP:0001783) | 2.68061876 |
| 32 | Dysmetric saccades (HP:0000641) | 2.64217437 |
| 33 | Cerebral aneurysm (HP:0004944) | 2.63577765 |
| 34 | Lipoatrophy (HP:0100578) | 2.63109325 |
| 35 | Obstructive sleep apnea (HP:0002870) | 2.61370549 |
| 36 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.61227795 |
| 37 | Absent frontal sinuses (HP:0002688) | 2.59795346 |
| 38 | Protrusio acetabuli (HP:0003179) | 2.55844373 |
| 39 | Hyperacusis (HP:0010780) | 2.53924411 |
| 40 | Atrioventricular block (HP:0001678) | 2.50002771 |
| 41 | Premature rupture of membranes (HP:0001788) | 2.48695591 |
| 42 | Increased mean platelet volume (HP:0011877) | 2.47982189 |
| 43 | Aortic dissection (HP:0002647) | 2.46693061 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 2.44512955 |
| 45 | Atrial fibrillation (HP:0005110) | 2.44068717 |
| 46 | Hand muscle atrophy (HP:0009130) | 2.43187752 |
| 47 | Deep venous thrombosis (HP:0002625) | 2.42314464 |
| 48 | Myotonia (HP:0002486) | 2.41473179 |
| 49 | Heart block (HP:0012722) | 2.39601210 |
| 50 | Cervical subluxation (HP:0003308) | 2.39257837 |
| 51 | Ulnar deviation of the wrist (HP:0003049) | 2.38921665 |
| 52 | Gingival bleeding (HP:0000225) | 2.35081974 |
| 53 | Primary atrial arrhythmia (HP:0001692) | 2.34807022 |
| 54 | Limb-girdle muscle atrophy (HP:0003797) | 2.34093975 |
| 55 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.33805387 |
| 56 | Abnormal platelet volume (HP:0011876) | 2.33717440 |
| 57 | Muscle stiffness (HP:0003552) | 2.33168326 |
| 58 | Abnormal atrioventricular conduction (HP:0005150) | 2.32618280 |
| 59 | Frequent falls (HP:0002359) | 2.30298219 |
| 60 | Distal arthrogryposis (HP:0005684) | 2.29000674 |
| 61 | Ventricular fibrillation (HP:0001663) | 2.27231967 |
| 62 | EMG: neuropathic changes (HP:0003445) | 2.26528361 |
| 63 | Supraventricular arrhythmia (HP:0005115) | 2.24636707 |
| 64 | Supraventricular tachycardia (HP:0004755) | 2.23484238 |
| 65 | Vascular tortuosity (HP:0004948) | 2.23193692 |
| 66 | Arterial tortuosity (HP:0005116) | 2.20429107 |
| 67 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18765029 |
| 68 | Ketosis (HP:0001946) | 2.18382575 |
| 69 | Ventricular arrhythmia (HP:0004308) | 2.16273799 |
| 70 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.14285698 |
| 71 | Osteolytic defects of the hand bones (HP:0009699) | 2.13480377 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13480377 |
| 73 | Hypoalphalipoproteinemia (HP:0003233) | 2.13288825 |
| 74 | Mitral stenosis (HP:0001718) | 2.12261708 |
| 75 | Palpitations (HP:0001962) | 2.11625943 |
| 76 | Epistaxis (HP:0000421) | 2.10621386 |
| 77 | Overgrowth (HP:0001548) | 2.09614181 |
| 78 | Spondylolisthesis (HP:0003302) | 2.09102412 |
| 79 | Round ear (HP:0100830) | 2.06893264 |
| 80 | Abnormality of the Achilles tendon (HP:0005109) | 2.06879859 |
| 81 | Ankle contracture (HP:0006466) | 2.06858828 |
| 82 | Dilated cardiomyopathy (HP:0001644) | 2.05000510 |
| 83 | Shallow orbits (HP:0000586) | 2.04123602 |
| 84 | Broad face (HP:0000283) | 2.03592058 |
| 85 | Flat acetabular roof (HP:0003180) | 2.03566317 |
| 86 | Aneurysm (HP:0002617) | 2.02318375 |
| 87 | Xanthomatosis (HP:0000991) | 2.02198909 |
| 88 | Achilles tendon contracture (HP:0001771) | 2.00684075 |
| 89 | Hypoplasia of the iris (HP:0007676) | 1.98787493 |
| 90 | Myopathic facies (HP:0002058) | 1.98710235 |
| 91 | Cholelithiasis (HP:0001081) | 1.96966231 |
| 92 | Mucopolysacchariduria (HP:0008155) | 1.95283221 |
| 93 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95283221 |
| 94 | Hyperammonemia (HP:0001987) | 1.95227614 |
| 95 | Nemaline bodies (HP:0003798) | 1.95073379 |
| 96 | Neck muscle weakness (HP:0000467) | 1.92153990 |
| 97 | Polycythemia (HP:0001901) | 1.91676807 |
| 98 | Ketoacidosis (HP:0001993) | 1.91301179 |
| 99 | Dilatation of the ascending aorta (HP:0005111) | 1.89214561 |
| 100 | Aortic aneurysm (HP:0004942) | 1.88438731 |
| 101 | Hamartoma of the eye (HP:0010568) | 1.87736401 |
| 102 | Striae distensae (HP:0001065) | 1.86834212 |
| 103 | Facial diplegia (HP:0001349) | 1.85091705 |
| 104 | Dysostosis multiplex (HP:0000943) | 1.84676830 |
| 105 | Mitral valve prolapse (HP:0001634) | 1.84567825 |
| 106 | Abnormality of the nasal mucosa (HP:0000433) | 1.84408354 |
| 107 | Scapular winging (HP:0003691) | 1.83692147 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81554577 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81554577 |
| 110 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81554577 |
| 111 | Syncope (HP:0001279) | 1.81375085 |
| 112 | Spinal rigidity (HP:0003306) | 1.78497363 |
| 113 | Reticulocytosis (HP:0001923) | 1.78456724 |
| 114 | Short nail (HP:0001799) | 1.78039751 |
| 115 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.77716909 |
| 116 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.77240798 |
| 117 | Atrophic scars (HP:0001075) | 1.76628059 |
| 118 | Peritonitis (HP:0002586) | 1.75734140 |
| 119 | Truncal obesity (HP:0001956) | 1.74465125 |
| 120 | Abnormal gallbladder physiology (HP:0012438) | 1.74120021 |
| 121 | Cholecystitis (HP:0001082) | 1.74120021 |
| 122 | Nasal polyposis (HP:0100582) | 1.73920276 |
| 123 | Hypercortisolism (HP:0001578) | 1.73666152 |
| 124 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.73583264 |
| 125 | Elfin facies (HP:0004428) | 1.73447380 |
| 126 | Enlarged penis (HP:0000040) | 1.72115857 |
| 127 | Lower limb amyotrophy (HP:0007210) | 1.72016250 |
| 128 | Distal lower limb amyotrophy (HP:0008944) | 1.71512782 |
| 129 | Abnormality of the 4th metacarpal (HP:0010012) | 1.70300211 |
| 130 | Conjunctival hamartoma (HP:0100780) | 1.69622576 |
| 131 | Renovascular hypertension (HP:0100817) | 1.68595366 |
| 132 | Resting tremor (HP:0002322) | 1.68295749 |
| 133 | Papillary thyroid carcinoma (HP:0002895) | 1.68224600 |
| 134 | Rectal prolapse (HP:0002035) | 1.67965275 |
| 135 | Insomnia (HP:0100785) | 1.67913316 |
| 136 | Generalized muscle weakness (HP:0003324) | 1.66906237 |
| 137 | Rapidly progressive (HP:0003678) | 1.65381172 |
| 138 | Germ cell neoplasia (HP:0100728) | 1.64318147 |
| 139 | Neonatal death (HP:0003811) | 1.64270517 |
| 140 | Hypoglycemic coma (HP:0001325) | 1.63960215 |
| 141 | Abnormal gallbladder morphology (HP:0012437) | 1.63168391 |
| 142 | Bruising susceptibility (HP:0000978) | 1.60713551 |
| 143 | Macroorchidism (HP:0000053) | 1.60637695 |
| 144 | Skin nodule (HP:0200036) | 1.60588655 |
| 145 | Difficulty walking (HP:0002355) | 1.60011160 |
| 146 | Persistence of primary teeth (HP:0006335) | 1.59338890 |
| 147 | Purpura (HP:0000979) | 1.58431356 |
| 148 | Neoplasm of the heart (HP:0100544) | 1.57743479 |
| 149 | Long clavicles (HP:0000890) | 1.57580477 |
| 150 | Abnormality of the frontal sinuses (HP:0002687) | 1.57402827 |
| 151 | Infantile muscular hypotonia (HP:0008947) | 1.56911439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.28834344 |
| 2 | PKN2 | 4.14990017 |
| 3 | TTN | 3.69840573 |
| 4 | PDK4 | 2.73786908 |
| 5 | PDK3 | 2.73786908 |
| 6 | PRKD3 | 2.44907482 |
| 7 | EEF2K | 2.44835240 |
| 8 | MAP3K10 | 2.41891904 |
| 9 | ICK | 2.29210103 |
| 10 | RIPK1 | 2.23833564 |
| 11 | ERN1 | 2.20636019 |
| 12 | LMTK2 | 2.15892518 |
| 13 | NEK1 | 2.13055662 |
| 14 | TESK1 | 1.87919491 |
| 15 | ZAP70 | 1.80330950 |
| 16 | FRK | 1.77514673 |
| 17 | BCKDK | 1.74120673 |
| 18 | PDGFRA | 1.71768692 |
| 19 | PHKG1 | 1.71143050 |
| 20 | PHKG2 | 1.71143050 |
| 21 | PTK6 | 1.68881263 |
| 22 | BRD4 | 1.59368768 |
| 23 | SIK1 | 1.54533230 |
| 24 | GRK6 | 1.51627739 |
| 25 | AKT3 | 1.50879592 |
| 26 | OBSCN | 1.49687874 |
| 27 | MAP2K3 | 1.45598166 |
| 28 | FGFR4 | 1.44080889 |
| 29 | PDK2 | 1.42173192 |
| 30 | TAOK1 | 1.41154857 |
| 31 | DMPK | 1.40006086 |
| 32 | EPHA2 | 1.35215903 |
| 33 | MAP3K7 | 1.33937357 |
| 34 | SIK3 | 1.31447191 |
| 35 | PRKD2 | 1.28914067 |
| 36 | PRPF4B | 1.27712289 |
| 37 | MET | 1.26355251 |
| 38 | MAP3K6 | 1.25541704 |
| 39 | STK38 | 1.17684758 |
| 40 | CDK12 | 1.13810220 |
| 41 | LRRK2 | 1.11030891 |
| 42 | SGK2 | 1.06586305 |
| 43 | PIK3CG | 1.05880351 |
| 44 | MARK2 | 1.05008445 |
| 45 | CAMK1D | 1.02081228 |
| 46 | KSR2 | 0.99755356 |
| 47 | MTOR | 0.99675527 |
| 48 | SIK2 | 0.99574163 |
| 49 | GRK5 | 0.96265014 |
| 50 | RET | 0.95531724 |
| 51 | DAPK2 | 0.91307273 |
| 52 | PTK2B | 0.90739811 |
| 53 | CAMK1G | 0.90186054 |
| 54 | BMX | 0.89601492 |
| 55 | LATS2 | 0.89192731 |
| 56 | TYRO3 | 0.88999824 |
| 57 | CAMKK1 | 0.87158085 |
| 58 | FGFR3 | 0.86598800 |
| 59 | MAP3K2 | 0.85740361 |
| 60 | KSR1 | 0.84817410 |
| 61 | LATS1 | 0.84621499 |
| 62 | FLT3 | 0.84243470 |
| 63 | MAPKAPK3 | 0.83900010 |
| 64 | TYK2 | 0.79674415 |
| 65 | PAK6 | 0.79140803 |
| 66 | SCYL2 | 0.78395295 |
| 67 | RIPK4 | 0.77027319 |
| 68 | LIMK1 | 0.75739362 |
| 69 | YES1 | 0.72524177 |
| 70 | HCK | 0.72372980 |
| 71 | MAP4K1 | 0.72127990 |
| 72 | ILK | 0.72032497 |
| 73 | EPHB1 | 0.71614849 |
| 74 | EPHA3 | 0.70553086 |
| 75 | PDK1 | 0.70463537 |
| 76 | PAK4 | 0.70359793 |
| 77 | PRKCH | 0.68589996 |
| 78 | MAP3K3 | 0.66930120 |
| 79 | DYRK1B | 0.64713707 |
| 80 | PDGFRB | 0.64532412 |
| 81 | MAP3K11 | 0.62901342 |
| 82 | EIF2AK1 | 0.62855247 |
| 83 | SGK494 | 0.62168005 |
| 84 | SGK223 | 0.62168005 |
| 85 | PRKAA1 | 0.61434916 |
| 86 | CDK6 | 0.60582917 |
| 87 | TRPM7 | 0.60145663 |
| 88 | DDR2 | 0.59936874 |
| 89 | BLK | 0.59205289 |
| 90 | NEK9 | 0.59073715 |
| 91 | ALK | 0.58985847 |
| 92 | PINK1 | 0.58784664 |
| 93 | RAF1 | 0.58511118 |
| 94 | ROCK2 | 0.58130248 |
| 95 | NEK2 | 0.57043729 |
| 96 | PTK2 | 0.56804907 |
| 97 | FGFR2 | 0.56363805 |
| 98 | PDPK1 | 0.55435197 |
| 99 | CSK | 0.55297790 |
| 100 | MAP2K4 | 0.54956421 |
| 101 | NTRK3 | 0.54633780 |
| 102 | FGFR1 | 0.54407607 |
| 103 | HIPK2 | 0.53744321 |
| 104 | PRKD1 | 0.53047610 |
| 105 | MAPK11 | 0.52218813 |
| 106 | SGK3 | 0.51152394 |
| 107 | WNK1 | 0.51126817 |
| 108 | TNK2 | 0.50632960 |
| 109 | RPS6KA2 | 0.49697067 |
| 110 | CSF1R | 0.49542857 |
| 111 | EPHB2 | 0.48636995 |
| 112 | CAMK2G | 0.48201605 |
| 113 | TGFBR2 | 0.48007665 |
| 114 | ROCK1 | 0.47546942 |
| 115 | JAK1 | 0.47546846 |
| 116 | MAP3K5 | 0.46221301 |
| 117 | JAK2 | 0.46008510 |
| 118 | PAK2 | 0.45391516 |
| 119 | MAPK12 | 0.44712584 |
| 120 | FYN | 0.43550078 |
| 121 | CDK4 | 0.42996458 |
| 122 | MAPK7 | 0.42669801 |
| 123 | TGFBR1 | 0.42174896 |
| 124 | STK24 | 0.42170916 |
| 125 | RPS6KA1 | 0.41989177 |
| 126 | CDC42BPA | 0.41387875 |
| 127 | CAMK2B | 0.41211236 |
| 128 | MAP2K6 | 0.40374860 |
| 129 | PAK3 | 0.40157755 |
| 130 | TBK1 | 0.39861396 |
| 131 | MAP3K9 | 0.38245848 |
| 132 | MAP2K1 | 0.36780796 |
| 133 | DAPK3 | 0.36580750 |
| 134 | CAMK4 | 0.36133555 |
| 135 | NTRK1 | 0.35905515 |
| 136 | STK3 | 0.35582491 |
| 137 | PRKAA2 | 0.35458983 |
| 138 | FER | 0.35408576 |
| 139 | MAP3K1 | 0.35371365 |
| 140 | MYLK | 0.34710235 |
| 141 | TAOK2 | 0.33898845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.54173230 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.31574245 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.16663441 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.56695064 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55460849 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20059204 |
| 7 | Carbon metabolism_Homo sapiens_hsa01200 | 1.96799725 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.86148386 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84943320 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83909540 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72517661 |
| 12 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.69909484 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.67501011 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.65294874 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.65258215 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.62785162 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.60760964 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59865514 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.55782477 |
| 20 | Insulin resistance_Homo sapiens_hsa04931 | 1.55618309 |
| 21 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.54799007 |
| 22 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.53065967 |
| 23 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.46557540 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39656317 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.38954517 |
| 26 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.34610382 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.34435401 |
| 28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.33026853 |
| 29 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.30839414 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.30578805 |
| 31 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.29067218 |
| 32 | Lysine degradation_Homo sapiens_hsa00310 | 1.24963133 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.23580637 |
| 34 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.21489874 |
| 35 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.20931328 |
| 36 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.19870555 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17236191 |
| 38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.16961627 |
| 39 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.15279151 |
| 40 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.14750566 |
| 41 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.11403896 |
| 42 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.09212568 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08936171 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08509715 |
| 45 | Long-term potentiation_Homo sapiens_hsa04720 | 1.06704504 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05957237 |
| 47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.03459276 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02680612 |
| 49 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00726623 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97201476 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96577801 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93469464 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93266258 |
| 54 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.91952168 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90500656 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90323157 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.90285462 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89743941 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88270325 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87203542 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.86984772 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86571034 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86381246 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84556019 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84409734 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.83809088 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80609609 |
| 68 | Prostate cancer_Homo sapiens_hsa05215 | 0.80481426 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80014067 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.79485175 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78563135 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77795687 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76214454 |
| 74 | Melanoma_Homo sapiens_hsa05218 | 0.76127014 |
| 75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76045839 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.74928540 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74874667 |
| 78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74391089 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73560775 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73465673 |
| 81 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72917134 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71293670 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71217711 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71208620 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71019663 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69137102 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68557381 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68423727 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67669462 |
| 90 | Gap junction_Homo sapiens_hsa04540 | 0.66926300 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66482957 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65403516 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65157854 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64583892 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.64133012 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.63752582 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63573575 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63150922 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.62331797 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61504650 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60824511 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.57874593 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56612866 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56481944 |
| 105 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55588163 |
| 106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55462337 |
| 107 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55190840 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55161891 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.55110138 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54904030 |
| 111 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54636070 |
| 112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54182040 |
| 113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54132362 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.53722490 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.53623249 |
| 116 | Peroxisome_Homo sapiens_hsa04146 | 0.52997531 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51817643 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.51264479 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50869224 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50574751 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50289409 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49481504 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49228139 |
| 124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47933183 |
| 125 | Tight junction_Homo sapiens_hsa04530 | 0.47828235 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.46845816 |
| 127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46016537 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.45978090 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45621489 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44691646 |
| 131 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42352484 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42139324 |
| 133 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41848708 |
| 134 | Renin secretion_Homo sapiens_hsa04924 | 0.39869596 |
| 135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39102810 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.37941867 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34185834 |
| 138 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33632154 |
| 139 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31489466 |
| 140 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31436627 |
| 141 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.30618479 |
| 142 | Endocytosis_Homo sapiens_hsa04144 | 0.29468391 |
| 143 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29237624 |

